不同甲状旁腺切除术式对继发性甲旁亢生化与临床转归的影响
研究纳入49例难治性继发性甲旁亢血液透析患者,比较甲状旁腺次全切除、全切除联合45或90个甲状旁腺碎片自体移植三种术式随访12个月的临床与实验室变化。三种术式均能有效控制病情,碎片数量与质量未影响系统iPTH及移植后iPTH水平,累积钙负荷与血管钙化评分相关。
要点
- 三种甲状旁腺切除术式均能有效控制难治性继发性甲旁亢。
- 自体移植碎片数量与质量不影响系统iPTH及移植后iPTH水平。
- 饥饿骨病期间累积钙负荷与术后血管钙化评分可能相关。
核心结论
- 三种甲状旁腺切除术式在临床和实验室指标上均有效控制难治性继发性甲旁亢。
研究设计与样本
- 纳入49例难治性继发性甲旁亢血液透析患者,分别接受甲状旁腺次全切除或全切除联合45或90个甲状旁腺碎片自体移植,随访12个月。
主要发现
- 基线血清iPTH中位数为1466(1087-2125)pg/mL。
- 血管钙化评分与血清iPTH(r=0.529;P=.002)及血清磷(r=0.389;P=.028)相关。
- Klotho表达与血清磷呈负相关(r=-0.4;P=.01)。
- 12个月后所有组血清iPTH和碱性磷酸酶显著控制,骨痛亦改善。
- 各治疗组血清iPTH达KDIGO推荐范围的比例相似,次全切除组有2例进展为临床未控制的高甲状旁腺功能亢进。
关键数值与推荐
- 饥饿骨病期间患者接受元素钙3786 g(1412-7580)。
- 随访结束时累积钙负荷与术后血管钙化评分呈正相关趋势(r=0.390;P=.06)。
- 甲状旁腺组织中PCNA、VDR、CasR、PIT1、FGFR1和Klotho的表达模式与血清系统iPTH水平或饥饿骨病持续时间无相关性。
临床怎么用
- 三种术式均可用于难治性继发性甲旁亢的甲状旁腺切除。
- 术后应关注饥饿骨病期间的钙负荷管理及其对血管钙化的潜在影响。
局限性
- 磷酸盐限制对人甲状旁腺Klotho表达及后续FGF23抵抗降低的影响需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Parathyroidectomy (PTx) decreases the mortality rate of refractory secondary hyperparathyroidism (rSHP) due to chronic kidney disease. A consensus regarding which techniques of PTx are associated with better outcomes is not available. The aims of this study are to evaluate the clinical and laboratory evolution of 49 hemodialysis patients with rSHP who underwent PTx using different techniques. METHODS: Patients underwent subtotal PTx (sub-PTx) or total PTx with autotransplantation (AT) of 45 (PTx-AT45) or 90 parathyroid fragments (PTx-AT90) and were followed for 12 months. We analyzed the expression of proliferating cell nuclear antigen (PCNA), calcium-sensing receptor (CasR), vitamin D receptor (VDR), fibroblast growth factor receptor-1 (FGFR1), sodium-dependent phosphate cotransporter-1 (PIT1), and Klotho in parathyroid glands. RESULTS: Baseline median serum intact parathyroid hormone (iPTH) levels were 1,466 (1,087-2,125) pg/mL; vascular calcification scores correlated with serum iPTH (r = 0.529; P = .002) and serum phosphate levels (r = 0.389; P = .028); and Klotho expression was negatively correlated with serum phosphate levels (r = -0.4; P = .01). After 12 months, serum iPTH and alkaline phosphatase levels were significantly controlled in all groups, as was bone pain. The proportions of patients with serum iPTH levels within the ranges recommended by Kidney Disease: Improving Global Outcomes were similar among the treatment groups. During the hungry bone disease (HBS), patients received 3,786 g (1,412-7,580) of elemental calcium, and a trend toward a positive correlation between the cumulative calcium load at the end of follow up and VC score post-PTx was noted (r = 0.390; P = .06). Two cases evolved to clinically uncontrolled hyperparathyroidism in the sub-PTx group. The expression patterns of PCNA, VDR, CasR, PIT1, FGFR1, and Klotho in parathyroid glands did not correlate with serum systemic iPTH levels or the duration of HBS. CONCLUSIONS: All 3 operative techniques were effective at controlling rSHP, both in clinical and laboratory terms. Neither the quantity nor quality of parathyroid fragments influenced serum systemic iPTH and AT-iPTH levels. The cumulative calcium load appeared to correlate with the VC score and may have affected its progression. The effects of phosphate restriction on Klotho expression in human parathyroid glands and the subsequent decrease in FGF23 resistance must be addressed in further studies.
引用
- Albuquerque RFC, Carbonara CEM, Martin RCT, et al. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism. Surgery. 2017. PMID: 29146232. doi:10.1016/j.surg.2017.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。